Our guiding vision

At Fera, we are passionately committed to expanding valuable treatment choices for the people who need them—to ensure the future is filled with quality therapeutic options to improve care, health and lives. We take this charge seriously, with a keen eye toward bettering the treatment of orphan and niche medical conditions.

We currently focus our efforts in ophthalmology, with the potential to expand our important work into other therapeutic arenas as the needs and opportunities arise.

Our goal is simple—to keep
more quality healthcare
choices alive for the people
who need them.

Frank DellaFera
Founder & CEO

Experienced leadership

Our management team has been carefully assembled and groomed to embody our vision and values. Each member is committed to making Fera your go-to resource and responsive partner in quality specialty pharmaceuticals. Our sights are set high to help all of us succeed.

Our senior leadership has a proven track record of identifying overlooked opportunities in specialty markets—to bring much-needed treatments to life. We have deep and extensive experience in the following

  • Eye care and other specialty pharmaceutical markets
  • Generic medicines
  • Acquisition, in-licensing, and the development and commercialization
    of products that address important medical needs
Frank J. DellaFera

Founder & CEO

Susan McDougal

Executive Vice President

Scott Florentino

VP, Business Development

John V. Rispoli


Michelle Kim, Pharm.D.

Senior Director, Quality and Regulatory Affairs

Nicholas DellaFera

Director, Commercial Development and Technical Operations